An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Short NJ 

PROVIDER: S-EPMC9278812 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature